目錄:MedChemExpress LLC>>生化試劑>> Elaiophylin | MCE
CAS | 37318-06-2 | 分子量 | 1025.27 |
---|---|---|---|
分子式 | C??H??O?? | 供貨周期 | 現貨 |
規格 | 1 mg | 貨號 | HY-15184 |
應用領域 | 醫療衛生,化工,生物產業,制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務。
CAS No. : 37318-06-2
產品活性:Elaiophylin (Azalomycin B; Gopalamicin; Efomycin E) is an autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells.
研究領域:Autophagy | Anti-infection
作用靶點:Autophagy | Antibiotic
In Vitro: Elaiophylin-mediated autophagy inhibition and lysosomal dysfunction affect ovarian cancer cell survival during hypoxia. Exposure to Elaiophylin (0.025-0.5 μM; 24 hours) causes a significant increase in ovarian cancer SKOV3 cell death in hypoxia conditions.
In both the SKOV3 and A2780 cell lines, Elaiophylin (0.25, 0.5, 0.75 μM; 24 hours) treatment leads to significant activation of cleaved CASP9/caspase-9 and PARP1 and downregulation of BIRC5/survivin in a concentration-dependent manner.
In Vivo: Treatment with 2 mg/kg Elaiophylin (given i.p. every 2 days for 21 days; in BALB/C athymic mice) significantly suppresses ovarian cancer SKOV3 cells growth compared with DMSO treatment, resulting in a 72% decrease in the average daily tumor growth rate compared with DMSO treatment .
Lower doses of Elaiophylin as a single agent exert significant antitumor activity, while higher doses lead to intestinal toxicity. Administration of a lower dose (2 mg/kg) of Elaiophylin as a single agent achieves a significant antitumor effect without toxicity in an orthotopic ovarian cancer model with metastasis. Toxic reactions are observed only in the 8 mg/kg group.
相關產品:Covalent Screening Library Plus | Bioactive Compound Library Plus | Anti-Infection Compound Library | Anti-Cancer Compound Library | Autophagy Compound Library | Covalent Screening Library | Antibiotics Library | (1R,2S,7R)-Sitafloxacin-d4 (hydrochloride) | Doxorubicin-13C,d3 (TFA) | Antibiotic A-33853 | Sulbactam-d2 (sodium) | Azlocillin sodium salt | Toyocamycin | Hispolon | SPR206 acetate | Doxycycline calcium | Staurosporine | Dihydrostreptomycin sulfate | WX-081 | SQ109 | Neomycin sulfate | Concanavalin A | Framycetin | Colistin sulfate | Amphotericin A | L-Lactic acid-2-13C1 | Griseofulvin-d3 | Monensin sodium salt | (R)-10,11-Dehydrocurvularin | (R)-Ofloxacin-d3 | Cefadroxil-d4 (hydrate) | Lincomycin-d3 | Bikaverin | Sitafloxacin monohydrate | Desacetylcephapirin sodium | Hypericin | Cephalexin monohydrate
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球僅有化合物庫,我們致力于為全球科研客戶提供前沿的高品質小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動劑涉及各熱門信號通路及疾病領;
• 產品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產品,廣泛應用于新藥研發、生命科學等科研項目;
• 提供虛擬篩選,離子通道篩選,代謝組學分析檢測分析,藥物篩選等專業技術服務;
• 設有專業的實驗中心和嚴格的質控、驗證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項質檢報告,確保產品的高純度、高品質;
• 產品的生物活性多經各國客戶實驗驗證;
• Nature, Cell, Science 等多種頂級期刊及制藥 Patent 收錄了MCE客戶的科研成果;
• 專業團隊跟蹤最新的制藥及生命科學研究進展,為您提供全球新的活性化合物;
• 與世界各大制藥公司及著名科研機構建立了長期的合作。